- 2.
- 5.Credentials, Clinics, and Costs: Stakeholders Respond to HRSA’s Psychedelic Therapy RFI (psychedelicalpha.com)
- 6.Scoop: Johnson & Johnson to Lead Delix Therapeutics’ $85M Series C (psychedelicalpha.com)
- 7.Paving the Way: Husseini Manji on Spravato’s Lessons for Psychedelic Drug Development (psychedelicalpha.com)
- 8.
- 9.The Psychedelic Practitioner Issue 6: Preparedness (People) (psychedelicalpha.com)
- 10.Two Years After Rejection, Resilient Quietly Refiles MDMA for PTSD Application (psychedelicalpha.com)
- 11.Smooth Sailing: Definium’s LSD Voyage Hits Primary and Key Secondary Endpoints in GAD (psychedelicalpha.com)
- 14.Psychedelic Policy Briefing (lucid.news)
- 19.From Sonora to Big Pharma: Kimon de Greef Traces the Strange Rise of 5-MeO-DMT (psychedelicalpha.com)
- 20.
- 21.Psychedelic Alpha Crossword: Summer 2026 (psychedelicalpha.com)
- 22.
- 23.Q1 2026: Oregon Psilocybin Services Update (psychedelicalpha.com)
- 24.A new magic mushroom discovered in Africa - Nature (news.google.com)
- 26.Psychedelic Funding Update: Q2 2026 (psychedelicalpha.com)
- 27.Entropy secures South African patent - The Australian (news.google.com)
- 30.Q3’26 Psychedelic Drug Development Pipeline: Bullseye Charts (psychedelicalpha.com)